Allelic loss at the GPx-1 locus in cancer of the head and neck

Ya Jun Hu, M. Eileen Dolan, Richard Bae, Herman Yee, Martin Roy, Robert Glickman, Lidia Kiremidjian-Schumacher, Alan M. Diamond

Research output: Contribution to journalArticle

Abstract

Glutathione peroxidase is a selenium-containing, antioxidant enzyme previously implicated in the risk and development of lung and breast cancer, in part the result of allelic loss at the GPx-1 locus. This study examined allelic loss at the same locus in squamous cell carcinomas of the head and neck. The frequency of a polymorphism at codon 198 resulting in either a leucine or a proline at that position was surveyed by comparing 133 DNA samples obtained from head and neck tumors and 517 samples obtained from cancer-free individuals. Tumor DNAs exhibited fewer pro/leu heterozygotes as compared to DNA obtained from the cancer-free population. Fewer GPx-1 heterozygotes were verified by determining the frequency of highly polymorphic alanine repeat sequences in the same gene. The analysis revealed an approximately 42% reduction in heterozygosity in the DNA from the tumor samples. In order to assess loss of heterozygosity (LOH) at the GPx-1 locus, DNA was genotyped from peripheral lymphocytes, tumor tissue, and microscopically normal tissues adjacent to the tumor, derived from the same patients. These studies indicated LOH at the GPx-1 locus in each of the three tumor/normal tissues sample sets examined. Furthermore, LOH in the microscopically normal tissues at the tumor margin occurred in two of the three sample sets examined. These data implicate GPx-1 in the development of squamous cell carcinoma the head and neck and suggest that allelic loss of this gene, or one tightly linked to it, is an early event in the development of this type of malignancy.

Original languageEnglish (US)
Pages (from-to)97-106
Number of pages10
JournalBiological Trace Element Research
Volume101
Issue number2
StatePublished - Nov 2004

Fingerprint

Loss of Heterozygosity
Head and Neck Neoplasms
Tumors
Neoplasms
DNA
Tissue
Genes
Heterozygote
Lymphocytes
Selenium
Glutathione Peroxidase
Polymorphism
Proline
Leucine
Alanine
Antioxidants
Codon
Lung Neoplasms
Neck
Enzymes

Keywords

  • Glutathione peroxidase
  • Head and neck cancer
  • Loss of heterozygosity
  • Polymorphism
  • Selenium
  • Selenoprotein

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Hu, Y. J., Dolan, M. E., Bae, R., Yee, H., Roy, M., Glickman, R., ... Diamond, A. M. (2004). Allelic loss at the GPx-1 locus in cancer of the head and neck. Biological Trace Element Research, 101(2), 97-106.

Allelic loss at the GPx-1 locus in cancer of the head and neck. / Hu, Ya Jun; Dolan, M. Eileen; Bae, Richard; Yee, Herman; Roy, Martin; Glickman, Robert; Kiremidjian-Schumacher, Lidia; Diamond, Alan M.

In: Biological Trace Element Research, Vol. 101, No. 2, 11.2004, p. 97-106.

Research output: Contribution to journalArticle

Hu, YJ, Dolan, ME, Bae, R, Yee, H, Roy, M, Glickman, R, Kiremidjian-Schumacher, L & Diamond, AM 2004, 'Allelic loss at the GPx-1 locus in cancer of the head and neck', Biological Trace Element Research, vol. 101, no. 2, pp. 97-106.
Hu, Ya Jun ; Dolan, M. Eileen ; Bae, Richard ; Yee, Herman ; Roy, Martin ; Glickman, Robert ; Kiremidjian-Schumacher, Lidia ; Diamond, Alan M. / Allelic loss at the GPx-1 locus in cancer of the head and neck. In: Biological Trace Element Research. 2004 ; Vol. 101, No. 2. pp. 97-106.
@article{026b274aedc84a19952d17e26d0b0191,
title = "Allelic loss at the GPx-1 locus in cancer of the head and neck",
abstract = "Glutathione peroxidase is a selenium-containing, antioxidant enzyme previously implicated in the risk and development of lung and breast cancer, in part the result of allelic loss at the GPx-1 locus. This study examined allelic loss at the same locus in squamous cell carcinomas of the head and neck. The frequency of a polymorphism at codon 198 resulting in either a leucine or a proline at that position was surveyed by comparing 133 DNA samples obtained from head and neck tumors and 517 samples obtained from cancer-free individuals. Tumor DNAs exhibited fewer pro/leu heterozygotes as compared to DNA obtained from the cancer-free population. Fewer GPx-1 heterozygotes were verified by determining the frequency of highly polymorphic alanine repeat sequences in the same gene. The analysis revealed an approximately 42{\%} reduction in heterozygosity in the DNA from the tumor samples. In order to assess loss of heterozygosity (LOH) at the GPx-1 locus, DNA was genotyped from peripheral lymphocytes, tumor tissue, and microscopically normal tissues adjacent to the tumor, derived from the same patients. These studies indicated LOH at the GPx-1 locus in each of the three tumor/normal tissues sample sets examined. Furthermore, LOH in the microscopically normal tissues at the tumor margin occurred in two of the three sample sets examined. These data implicate GPx-1 in the development of squamous cell carcinoma the head and neck and suggest that allelic loss of this gene, or one tightly linked to it, is an early event in the development of this type of malignancy.",
keywords = "Glutathione peroxidase, Head and neck cancer, Loss of heterozygosity, Polymorphism, Selenium, Selenoprotein",
author = "Hu, {Ya Jun} and Dolan, {M. Eileen} and Richard Bae and Herman Yee and Martin Roy and Robert Glickman and Lidia Kiremidjian-Schumacher and Diamond, {Alan M.}",
year = "2004",
month = "11",
language = "English (US)",
volume = "101",
pages = "97--106",
journal = "Biological Trace Element Research",
issn = "0163-4984",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Allelic loss at the GPx-1 locus in cancer of the head and neck

AU - Hu, Ya Jun

AU - Dolan, M. Eileen

AU - Bae, Richard

AU - Yee, Herman

AU - Roy, Martin

AU - Glickman, Robert

AU - Kiremidjian-Schumacher, Lidia

AU - Diamond, Alan M.

PY - 2004/11

Y1 - 2004/11

N2 - Glutathione peroxidase is a selenium-containing, antioxidant enzyme previously implicated in the risk and development of lung and breast cancer, in part the result of allelic loss at the GPx-1 locus. This study examined allelic loss at the same locus in squamous cell carcinomas of the head and neck. The frequency of a polymorphism at codon 198 resulting in either a leucine or a proline at that position was surveyed by comparing 133 DNA samples obtained from head and neck tumors and 517 samples obtained from cancer-free individuals. Tumor DNAs exhibited fewer pro/leu heterozygotes as compared to DNA obtained from the cancer-free population. Fewer GPx-1 heterozygotes were verified by determining the frequency of highly polymorphic alanine repeat sequences in the same gene. The analysis revealed an approximately 42% reduction in heterozygosity in the DNA from the tumor samples. In order to assess loss of heterozygosity (LOH) at the GPx-1 locus, DNA was genotyped from peripheral lymphocytes, tumor tissue, and microscopically normal tissues adjacent to the tumor, derived from the same patients. These studies indicated LOH at the GPx-1 locus in each of the three tumor/normal tissues sample sets examined. Furthermore, LOH in the microscopically normal tissues at the tumor margin occurred in two of the three sample sets examined. These data implicate GPx-1 in the development of squamous cell carcinoma the head and neck and suggest that allelic loss of this gene, or one tightly linked to it, is an early event in the development of this type of malignancy.

AB - Glutathione peroxidase is a selenium-containing, antioxidant enzyme previously implicated in the risk and development of lung and breast cancer, in part the result of allelic loss at the GPx-1 locus. This study examined allelic loss at the same locus in squamous cell carcinomas of the head and neck. The frequency of a polymorphism at codon 198 resulting in either a leucine or a proline at that position was surveyed by comparing 133 DNA samples obtained from head and neck tumors and 517 samples obtained from cancer-free individuals. Tumor DNAs exhibited fewer pro/leu heterozygotes as compared to DNA obtained from the cancer-free population. Fewer GPx-1 heterozygotes were verified by determining the frequency of highly polymorphic alanine repeat sequences in the same gene. The analysis revealed an approximately 42% reduction in heterozygosity in the DNA from the tumor samples. In order to assess loss of heterozygosity (LOH) at the GPx-1 locus, DNA was genotyped from peripheral lymphocytes, tumor tissue, and microscopically normal tissues adjacent to the tumor, derived from the same patients. These studies indicated LOH at the GPx-1 locus in each of the three tumor/normal tissues sample sets examined. Furthermore, LOH in the microscopically normal tissues at the tumor margin occurred in two of the three sample sets examined. These data implicate GPx-1 in the development of squamous cell carcinoma the head and neck and suggest that allelic loss of this gene, or one tightly linked to it, is an early event in the development of this type of malignancy.

KW - Glutathione peroxidase

KW - Head and neck cancer

KW - Loss of heterozygosity

KW - Polymorphism

KW - Selenium

KW - Selenoprotein

UR - http://www.scopus.com/inward/record.url?scp=9644266978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644266978&partnerID=8YFLogxK

M3 - Article

C2 - 15557674

AN - SCOPUS:9644266978

VL - 101

SP - 97

EP - 106

JO - Biological Trace Element Research

JF - Biological Trace Element Research

SN - 0163-4984

IS - 2

ER -